High expression of <scp>CD</scp>44v9 and <scp>xCT</scp> in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazine
Fumitaka Wada(Kurume University), Takuji Torimura(Omuta hospital), Atsutaka Masuda(Kurume University), Hirohisa Yano(Kurume University), Jun Akiba(Kurume University), Yu Ikezono(Kurume University), Tõru Nakamura, Hideki Iwamoto, Tatsuyuki Kakuma(Kurume University), Takashi Niizeki(Kurume University), Toshimitsu Tanaka(Kurume University), Takahiko Sakaue(Kurume University), Mitsuhiko Abe(Kurume University), Hironori Koga(Kurume University)
Cited by 83
Related Papers
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
|Journal of Hepatology|2016|504
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
|Liver International|2020|410